Major pharmaceutical companies, business associations and experts from the EU and the EEU discussed a common position on the formation of a unified pharmaceutical market from Lisbon to Vladivostok, and also welcomed the Association of Russian Pharmaceutical Manufacturers' joining the Lisbon-Vladivostok Initiative Moscow, April 28, 2021. The first meeting of the expert group on the formation of a unified pharmaceutical market (Task Force Pharma) in the European Union (EU) and the Eurasian Economic Union (EAEU) was held in the House of German Economy. The expert group was created within the framework of the Lisbon-Vladivostok Initiative and is aimed at developing a balanced approach of business to the formation of a unified pharmaceutical market. On the eve of the meeting of the group, a solemn ceremony of joining the Association of Russian Pharmaceutical Manufacturers (ARFP) to the Lisbon-Vladivostok Initiative was held. 
Ulf Schneider, member of the Supervisory Board of the FBA EAC, Chairman of the Board of the Lisbon-Vladivostok Initiative, said: "The Common Economic Space from Lisbon to Vladivostok will help protect the health of the population of both unions and will be the key to strengthening security in Europe."
ARFP CEO Viktor Dmitriev also noted: "Today we are experiencing far from the best political relations. As experience shows, in such situations, the people’s diplomacy becomes the driver of the rapprochement processes. Business represents the most enterprising and mobile part of the population, so this initiative finds support in business circles. In our field, this will create common rules of the game and common approaches to the development of the pharmaceutical business in the EU and the EAEU, which in turn will have a beneficial effect on the availability and cost of medicines in the space from Lisbon to Vladivostok." At the following meeting of the working group, more than 30 experts from France, Germany, Portugal, Switzerland, Russia and Armenia discussed the issues of harmonization of legislation and outlined the main legislative barriers to the development of the pharmaceutical business.
The program document (Position paper) on the results of the work of Task Force Pharma will be sent to the leadership of the European Commission and the Eurasian Economic Commission in June 2021. About the Lisbon-Vladivostok Initiative: In 2015, the European business community launched an initiative to promote the idea of creating a unified economic space on the territory of the European Union (EU) and the Eurasian Economic Union (EAEU) – the Lisbon-Vladivostok Business Initiative. The foundation of the Initiative is the need of the business community for economic integration and expansion of economic cooperation in the Eurasian space. The initiative already unites more than 100 companies, as well as the largest business associations from 12 EU and EAEU member states. In 2020, the Initiative received its organizational formalization in the face of working bodies: the management board and a number of expert working groups in specific areas. Events dedicated to the promotion and further promotion of the Initiative are held on a regular basis. The participants of the events held within the framework of the Initiative are business leaders and owners, officials, as well as authoritative members of the expert community. More detailed information can be found on the website and social networks:

From Lisbon to Vladivistok